GSK's three-in-one inhaler gets positive opinion from EU agency

(Reuters) - GlaxoSmithKline said on Friday that a European Medicines Agency (EMA) panel has recommended the company's three-in-one inhaled lung drug.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news